Evotec AG (EVO) vs Ironwood Pharmaceuticals, Inc. (IRWD)
- Evotec AG EVO 1.38 −2.82%
- Ironwood Pharmaceuticals, Inc. IRWD 3.50 −7.16%
Evotec AG and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $623.0M against $504.4M — 1.2× the size. Evotec AG has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 4.4×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 26.2% against 2.15%. Ironwood Pharmaceuticals, Inc. has the higher net margin (33.4% vs −26.2%) and the higher return on invested capital (101.6% vs 0.00%). Across the 18 metrics below, Ironwood Pharmaceuticals, Inc. leads on 12 and Evotec AG on 6.
Valuation
Profitability
| Metric | EVO | IRWD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 11.42% | 100.00% | 53.94% |
| Operating margin | (21.35%) | 60.15% | 0.00% |
| Net margin | (26.20%) | 33.36% | 0.00% |
| Free cash flow margin | 0.00% | 47.66% | 0.00% |
| Return on equity | 0.00% | (55.26%) | (0.40%) |
| Return on assets | 0.00% | 41.35% | (3.32%) |
| Return on invested capital | 0.00% | 101.61% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack